Alexander Robinson


UK & European Patent Attorney

MChem, DPhil, EPA, CPA

Alex handles a mixture of opposition and prosecution work relating to subject matter in the chemical sciences, with a particular focus on pharmaceuticals. He takes a close interest in wider issues of law and policy affecting intellectual property, and is a member of the editorial board of the Encyclopedia of UK and European Patent Law.

LinkedIn Email

Alex has a substantial practice in contentious inter partes proceedings before the European Patent Office’s (EPO) Opposition Division and Boards of Appeal, representing both opponents and patent owners and including the defence of commercially significant patents against complex multi-party oppositions. He also handles the prosecution of global patent portfolios covering authorised medicinal products, and provides advice relating to Supplementary Protection Certificates. His practice also encompasses infringement, validity and freedom to operate matters, including topics such as the Bolar and research exemptions and data exclusivity.

His work has a particular focus on small molecule pharmaceuticals, dosage regimens, dosage forms, biomarkers and diagnostics. However, with an interdisciplinary academic background spanning chemistry, physics and molecular biology he also has experience in handling subject matter as diverse as polymers, inorganic semiconductor materials, OLEDs, dye-sensitised solar cells, and CRISPR-Cas technology.

Alongside his client work, Alex is a member of the editorial board of the Encyclopedia of UK and European Patent Law, which is updated twice a year with the latest developments in patent and SPC case law and practice before the patent offices and courts.

Alex holds a first-class MChem degree in chemistry and a DPhil in biophysical chemistry, both from the University of Oxford, and a Postgraduate Certificate in Intellectual Property Law from Brunel University London. His doctoral research focused on spectroscopic studies of quantum entanglement phenomena in the photolyase/cryptochrome family of photoreceptor proteins, which are involved in the repair of UV-induced damage to DNA, the regulation of circadian rhythms, and potentially in the perception of magnetic fields by animals. He also spent time carrying out research at the Université Pierre et Marie Curie in Paris.

After qualifying as a UK and European patent attorney in 2015, Alex joined Mathys & Squire in 2018 from another top-tier UK firm, where he was named as a ‘Rising star to watch’ in Managing IP’s IP Stars rankings and recommended in The Legal 500. Since joining Mathys & Squire his work has included a significant number of EPO oppositions and appeals, such as representing patent owners in relation to authorised pharmaceutical products, and (as opponent) opposition work in relation to patents covering CRISPR-Cas technologies, including applications of AI in sequence design. He has also delivered presentations on recent SPC case law as part of the firm’s latest series of webinars.

Alex is a Fellow of the Chartered Institute of Patent Attorneys (CIPA) and a member of the European Patent Institute (EPI). He is also a member of the Biochemical Society.

Latest articles by Alexander Robinson